conivaptan has been researched along with Liver Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, GL; O'Leary, JG | 1 |
1 other study(ies) available for conivaptan and Liver Failure
Article | Year |
---|---|
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease.
Topics: Adult; Aged; Benzazepines; Drug Administration Schedule; Female; Humans; Hyponatremia; Liver Failure; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk; Sodium; Time Factors; Treatment Outcome | 2009 |